Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Eisai Co., Ltd.
  6. News
  7. Summary
    4523   JP3160400002

EISAI CO., LTD.

(4523)
  Report
Delayed Japan Exchange  -  01:00 2022-11-25 am EST
9468.00 JPY   -0.13%
11/24Eisai to present latest data on fycompa ciii at the 76th american epilepsy society annual meeting
AQ
11/23Eisai to Present Latest Data on Perampanel at the 76th American Epilepsy Society (AES) Annual Meeting
AQ
11/23Eisai to Present Latest Data on Fycompa CIII at the 76th American Epilepsy Society Annual Meeting
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Wall Street jumps over 1% in choppy trading as yields dip

09/28/2022 | 12:51pm EST

(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.)

*

Apple down 2.83% on move to drop iPhone production boost

*

U.S. 10-yr Treasury yields ease from 12-year highs

*

Biogen soars on landmark Alzheimer's data

*

Indexes up: Dow 1.55%, S&P 1.65%, Nasdaq 1.57%

Sept 28 (Reuters) - U.S stock indexes jumped more than 1% in volatile trading on Wednesday as easing Treasury yields lifted rate-sensitive growth stocks, while losses in Apple Inc after it dropped plans to boost iPhone production hurt the technology sector.

Equity markets also got a boost from a Bank of England decision to restore financial stability by buying as many long-dated government bonds as needed. The move lifted British bond prices and pushed global benchmark yields lower.

The yield on the U.S. 10-year Treasury bill came off 12-year highs to hit the day's low of 3.751%, while Germany's 10-year government bond yield, the benchmark for the euro zone, fell after touching a 11-year high.

Investors also keenly listened to comments from Federal Reserve officials on the path of monetary policy, with Atlanta Fed President Raphael Bostic backing another 75 basis-point interest rate hike in November.

Much to the market's relief, Fed Chair Jerome Powell did not comment on monetary policy or the U.S. economic outlook on Wednesday.

Amid an aggressive push by the Fed to raise borrowing costs even at the risk of slowing down economic growth, Wall Street's main indexes remained in a bear market, with the S&P 500 recording its lowest close in almost two years on Tuesday.

"Can the move up in stock prices today be sustained for a period of time? Well, maybe a couple of days, but I don't think we can use the expression 'out of the woods' with the concerns about the economy getting deeper," said Hugh Johnson, chief economist of Hugh Johnson Economics in Albany, New York.

Meanwhile, shares of the world's most valuable public company lost 2.83% after Bloomberg reported that Apple told suppliers to curtail efforts to increase assembly of its iPhone 14 products by as many as 6 million units in the second half of this year.

"Apple's announcement...does play into that notion that we're already in a situation where it's harder for companies to start to see their profit continue to hold at previous levels during the recovery from the pandemic," said Daniela Hathorn, market analyst, Capital.com.

Among the 11 S&P 500 sector indexes, technology was the sole decliner, down 0.5% due to Apple's drag. Leading the gains were communication services, healthcare and energy, up between 2% and 2.5%.

At 12:19 p.m. ET, the Dow Jones Industrial Average was up 452.74 points, or 1.55%, at 29,587.73, the S&P 500 was up 60.32 points, or 1.65%, at 3,707.61, and the Nasdaq Composite was up 169.50 points, or 1.57%, at 10,999.00.

Biogen shares surged 37.47% after its Alzheimer's drug, developed with Japanese partner Eisai, succeeded in slowing cognitive decline.

Eli Lilly & Co, which is also developing an Alzheimer's drug, rose 8.17% and was among the biggest boosts to the S&P 500 index.

Advancing issues outnumbered decliners by a 6.43-to-1 ratio on the NYSE and by a 4.02-to-1 ratio on the Nasdaq.

The S&P index recorded one new 52-week high and 30 new lows, while the Nasdaq recorded 21 new highs and 192 new lows. (Reporting by Shreyashi Sanyal, Susan Mathew and Ankika Biswas in Bengaluru; Editing by Vinay Dwivedi and Arun Koyyur)


ę Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
APPLE INC. -1.96% 148.11 Delayed Quote.-14.92%
BIOGEN INC. 0.56% 305.15 Delayed Quote.27.19%
EISAI CO., LTD. -0.13% 9468 Delayed Quote.44.97%
All news about EISAI CO., LTD.
11/24Eisai to present latest data on fycompa ciii at the 76th american epilepsy society annu..
AQ
11/23Eisai to Present Latest Data on Perampanel at the 76th American Epilepsy Society (AES) ..
AQ
11/23Eisai to Present Latest Data on Fycompa CIII at the 76th American Epilepsy Society Annu..
CI
11/22To Develop Japan's First Blood Biomarker-Based Diagnostic Workflow for Dementia Shimadz..
AQ
11/20Eisai to Present Full Findings from Lecanemab Confirmatory Phase 3 Clinical Trial (Clar..
AQ
11/18Interest-Rate Outlook Undercuts Tokyo Equities as Japan Inflation Hits 40-Year High
MT
11/16Metoject Subcutaneous Injection Syringe (Methotrexate) Launched In Japan For Rheumatoid..
AQ
11/15Bank Stocks, Stronger Yen Drive Tokyo Equities Into Green
MT
11/15Casma Therapeutics, Inc. announced that it has received $46 million in funding from a g..
CI
11/14MarketScreener's World Press Review : November 14, 2..
MS
More news
Financials
Sales 2023 736 B 5 287 M 5 287 M
Net income 2023 57 738 M 415 M 415 M
Net cash 2023 177 B 1 269 M 1 269 M
P/E ratio 2023 48,8x
Yield 2023 1,71%
Capitalization 2 716 B 19 511 M 19 511 M
EV / Sales 2023 3,45x
EV / Sales 2024 3,21x
Nbr of Employees 11 322
Free-Float 93,3%
Chart EISAI CO., LTD.
Duration : Period :
Eisai Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EISAI CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Last Close Price 9 468,00 JPY
Average target price 8 453,85 JPY
Spread / Average Target -10,7%
EPS Revisions
Managers and Directors
Haruo Naito Manager-Research & Development Promotions
Tatsuyuki Yasuno Manager-Corporate Planning
Yasuhiko Katoh Chairman
Keisuke Naito Executive Officer & Head-Global IT Headquarters
Yasushi Okada Manager-Business Planning
Sector and Competitors
1st jan.Capi. (M$)
EISAI CO., LTD.44.97%19 511
JOHNSON & JOHNSON3.61%463 391
ELI LILLY AND COMPANY30.95%347 052
ABBVIE INC.17.89%282 189
PFIZER, INC.-16.66%276 231
MERCK & CO., INC.40.27%272 555